Aservo EquiHaler
Active substance
ATC code
Species
Horse
Indications
For the alleviation of clinical signs of severe equine asthma (formerly known as Recurrent Airway Obstruction– (RAO), Summer Pasture Associated Recurrent Airway Obstruction – (SPA-RAO)).
Dose to be administered and administration route
Inhalation use.
The number of actuations to be administered is the same for all horses. The total treatment duration is 10 days:
- Day 1 to 5:
8 actuations (corresponding to 2,744 µg ciclesonide) administered twice daily approximately 12 h apart
- Day 6 to 10:
12 actuations (corresponding to 4,116 µg ciclesonide) administered once daily approximately 24 h apart.
The onset of clinical improvement may take several days. The 10 days treatment schedule should normally be completed. In case of any concerns related to the treatment the responsible veterinarian should be consulted.
The Aservo EquiHaler contains sufficient inhalation solution for one horse for the entire treatment duration of the 10 days and an additional amount covering priming and potential losses during administration.
Treatment schedule for use:
|
Treatment days 1 to 5 |
Treatment days 6 to 10 |
|
8 actuations morning and evening approximately 12 h apart |
12 actuations once daily approximately 24 h apart |
The “Instructions for handling and use of the Aservo EquiHaler” is provided in section “Other information” of the package leaflet.
Adverse reactions
Horse:
|
Common (1 to 10 animals / 100 animals treated): |
Nasal discharge.* |
* mild
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for respective contact details.
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 04491/5003 |
| EAN | 5012917010466 |
